Ifp Advisors, Inc Lannett CO Inc Transaction History

Ifp Advisors, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$0.47 - $0.87 $235 - $435	500 New	500 $8,000
Q2 2022 Aug 12, 2022	SELL	$0.47 - $0.87 $235 - $435	-500 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$0.75 - $1.77 $375 - $885	500 New	500 $0
Q3 2021 Oct 06, 2021	SELL	$2.91 - $4.83 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$4.17 - $5.74 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$5.28 - $9.64 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$5.75 - $7.13 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$4.9 - $7.12 $0 - $0	0 New	0 $0

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.